Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches

par Ardon, C.B., Wang, C., Prens, E.P., van Straalen, K.R.
Publié dans Br J Dermatol (2020)

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

par Mouton, J W, Horrevorts, A M, Mulder, P G, Prens, E P, Michel, M F
Publié 1990

High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa

par van Straalen, K.R., Boeren, A.M.P., Wervers, K., Prens, E.P., Vis, M.
Publié dans Br J Dermatol (2020)

Lentigo maligna – anatomic location as a potential risk factor for recurrences after non‐surgical treatment

par Greveling, K., van der Klok, Th., van Doorn, M.B.A., Noordhoek Hegt, V., Prens, E.P.
Publié dans J Eur Acad Dermatol Venereol (2016)

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study

par Vossen, A.R.J.V., Ardon, C.B., van der Zee, H.H., Lubberts, E., Prens, E.P.
Publié dans Br J Dermatol (2019)

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

par Vossen, A.R.J.V., van der Zee, H.H., Davelaar, N., Mus, A.M.C., van Doorn, M.B.A., Prens, E.P.
Publié dans J Eur Acad Dermatol Venereol (2018)

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

par Jemec, G.B.E., Okun, M.M., Forman, S.B., Gulliver, W.P.F., Prens, E.P., Mrowietz, U., Armstrong, A.W., Geng, Z., Gu, Y., Williams, D.A., Teixeira, H.D., Kimball, A.B.
Publié dans Br J Dermatol (2019)

A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance

par Vossen, A.R.J.V., van Straalen, K.R., Swagemakers, S.M.A., de Klein, J.E.M.M., Stubbs, A.P., Venter, D.J., van der Zee, H.H., van der Spek, P.J., Prens, E.P.
Publié dans J Eur Acad Dermatol Venereol (2020)

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group

par Zouboulis, C.C., Bechara, F.G., Dickinson‐Blok, J.L., Gulliver, W., Horváth, B., Hughes, R., Kimball, A.B., Kirby, B., Martorell, A., Podda, M., Prens, E.P., Ring, H.C., Tzellos, T., van der Zee, H.H., van Straalen, K.R., Vossen, A.R.J.V., Jemec, G.B.E.
Publié dans J Eur Acad Dermatol Venereol (2018)

Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II

par Thorlacius, L., Garg, A., Ingram, J.R., Villumsen, B., Riis, P. Theut, Gottlieb, A.B., Merola, J.F., Dellavalle, R., Ardon, C., Baba, R., Bechara, F.G., Cohen, A.D., Daham, N., Davis, M., Emtestam, L., Fernández-Peñas, P., Filippelli, M., Gibbons, A., Grant, T., Guilbault, S., Gulliver, S., Harris, C, Harvent, C., Houston, K., Kirby, J.S., Matusiak, L., Mehdizadeh, A., Mojica, T., Okun, M., Orgill, D., Pallack, L., Parks-Miller, A., Prens, E.P., Randell, S., Rogers, C., Rosen, C.F., Choon, S.E., van der Zee, H.H., Christensen, R., Jemec, G.B.E.
Publié dans Br J Dermatol (2018)

Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017

par van der Kraaij, G.E., Balak, D.M.W., Busard, C.I., van Cranenburgh, O.D., Chung, Y., Driessen, R.J.B., de Groot, M., de Jong, E.M.G.J., Kemperman, P.M.J.H., de Kort, W.J.A., Karsch, S.A., Lamberts, A., Lecluse, L.L.A., van Lümig, P.P.M., Menting, S.P., Prens, E.P., van den Reek, J.M.P.A., Seyger, M.M.B., Thio, H.B., Veldkamp, W.R., Wakkee, M., Nast, A., Jacobs, A., Rosumeck, S., Spuls (Chair), P.I.
Publié dans Br J Dermatol (2019)